Unfounded and unscientific claims have no place in legitimate healthcare RACGP President Dr Bastian Seidel expresses his dismay at news of the approval of the Therapeutic Goods Administration’s list of ‘permitted indications’.
Alarming health claims must not appear on complementary medicine: RACGP President Many of the items included on the Therapeutic Goods Administration’s list of ‘permitted indications’ make unfounded and unscientific claims that could lead to patient harms, RACGP President Dr Bastian Seidel writes for newsGP.
RACGP appeals for urgent political focus on rising patient costs The RACGP is calling on Australia’s political leaders to develop an immediate solution to patients’ rising out-of-pocket costs.
ISQua accredits RACGP Standards for general practices The fifth edition of the RACGP Standards for general practices (the Standards) has been awarded accreditation by the International Society for Quality and Safety in Health Care.
Survey reveals alcohol’s impact on emergency departments New data from the Australasian College for Emergency Medicine has revealed that up to 20% of patients in state and territory emergency departments are affected by alcohol.
Heavy menstrual bleeding: Understanding the options Hayley Harrison served as a consumer advocate for the Australian Commission of Safety and Quality in Health Care on the ‘Heavy menstrual bleeding clinical standard’, bringing her lived experience of the condition to the working group.
Baby boomers and the modern day sexual revolution: Part 2 A research expert on addiction education and training is contacted by the managers of an aged care facility who, somewhat baffled, tell her, ‘We know people here are using cannabis. We can smell it.’
New clinical standard to help address variation in care for heavy menstrual bleeding The Australian Commission on Safety and Quality in Health Care (ACSQHC) recently launched its Heavy menstrual bleeding clinical care standard (the Standard), with the goals of informing best practice for healthcare providers and empowering the 25% of women of reproductive age who experience the condition.